{
    "eid": "2-s2.0-85087673437",
    "title": "A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post\u2013kidney transplant recipient",
    "cover-date": "2021-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Transplantation",
            "@code": "2747",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "COVID-19",
        "favipiravir",
        "kidney transplant recipient",
        "tocilizumab"
    ],
    "authors": [
        "Theerachai Thammathiwat",
        "Somkanya Tungsanga",
        "Kanitha Tiankanon",
        "Pattama Torvorapanit",
        "Worawat Chumpangern",
        "Suwasin Udomkarnjananun",
        "Yingyos Avihingsanon",
        "Thitiwat Sriprasart",
        "Nattachai Srisawat",
        "Kamonwan Jutivorakool",
        "Leilani Paitoonpong",
        "Opass Putcharoen",
        "Natavudh Townamchai"
    ],
    "citedby-count": 24,
    "ref-count": 16,
    "ref-list": [
        "Clinical characteristics of coronavirus disease 2019 in China",
        "The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis",
        "Identification of kidney transplant recipients with coronavirus disease 2019",
        "COVID-19 infection in kidney transplant recipients",
        "COVID-19 in post-transplantation patients- report of two cases",
        "Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation?",
        "Immunosuppression drug-related and clinical manifestation of coronavirus disease 2019: a therapeutical hypothesis",
        "The occurrence of diarrhea in COVID-19 patients",
        "Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus",
        "Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection",
        "Experimental treatment with favipiravir for COVID- 19: an open-label control study",
        "Favipiravir versus Arbidol for COVID- 19: a randomized clinical trial",
        "Interleukin-6 as a potential biomarker of COVID-19 progression",
        "Tocilizumab treatment in COVID-19: a single center experience",
        "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pitsanulok",
            "@id": "60022498",
            "affilname": "Naresuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022498",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}